AMCP joins 30+ organizations representing population health decision makers, biopharmaceutical and medical device manufacturers, patient advocacy groups, health care providers, health economists, and others in joint comments to the FDA advocating for time
AMCP joins 30+ organizations representing population health decision makers, biopharmaceutical and medical device manufacturers, patient advocacy groups, health care providers, health economists, and others in joint comments to the FDA advocating for time